Martin Lush, Global VP of Pharma Biotech and Medical Devices, and John Johnson, VP of Pharma Biotech, will be at the event and look forward to seeing you there. NSF is also delighted to announce Lush has joined the Pharma Integrates steering committee.
This year’s conference will take place on 15-16 November at the Grange City Hotel, London.
It provides a top-tier programme of interviews and interactive debate through led panel discussions, which will focus on the strategic issues facing the drug manufacturing sector and once again, play a vital role in shaping pharma’s future.
On 16 November, Lush will facilitate two panel discussions on how to improve efficiency and effectiveness of pharma R&D.
The two sessions and times are as follows:
Rethinking Pharma Productivity (10.05 – 11.05)
This session is all round changing the way pharma thinks about production, processes and people. As the productivity imperative looms ever larger, companies need to rethink their strategic options and put productivity at the heart of any upcoming change programme or improvement agenda.
De-Risking Pharma (14:40 – 15:40)
Risk management is a valuable component of an effective quality system, but achieving a shared understanding of the application of risk management is difficult. Given that risk and the effective prediction of risk needs intuitive data interpretation, this session will look beyond the numbers and examine how pharma views, manages and assesses risk.
Make sure to visit our stand and get involved in our discussions around ‘how the mighty fall’, identify at what stage your company is and help recognise the main activities pharmaceutical companies should be doing to prevent organisational decline in this ever-changing and demanding industry.
Book your tickets for the event on the Pharma Integrates website. You will also find the full programme of conference interviews and panel debates including more information on Lush’s sessions. Early bird and multiple delegate discounts are available for a limited period.
